Vaccines broader value advisory board
On the 11th of November Pfizer organized an advisory board on the broader value of vaccines. Experts of the field were invited to provide feedback on the broader benefits of vaccines and how to apply to HTA assessment to ensure full value of vaccines has been captured.
During the meeting, the different frameworks available and the usefulness of these frameworks for decision making were also discussed. Inge van der Putten was invited to give her expert opinion based on her findings on the PhD thesis: Using information on the broader economic impact of vaccines in evidence-informed decision making.
Inge van der Putten
Also read
-
Kira moved from Northern Germany to Maastricht for a Double Degree Programme between the University of Maastricht and Bremen. She combined her master’s 'Healthcare Provision, Management, and Economics’ with our international perspective on health in the master's ‘Governance and Leadership in...
-
Estefania works for the European Patient’s Forum, the leading voice of patient organisations in Europe. Her role involves creating a dialogue between patient organisations and stakeholders for European projects. To uphold patient empowerment through patient advisory boards, Estefania relies on...
-
Rianne strives to create value for clinicians and patients at Maastro using data science.